SCHEMBL6060468

SCHEMBL6060468

CC(=O)OCCCCCCCCCCCO

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.58
ACHE P22303 6/20 0.50
LMNA P02545 2/20 0.47
APOBEC3A P31941 1/20 0.47
APOBEC3G Q9HC16 1/20 0.47
TSHR P16473 3/20 0.44
CHRM5 P08912 2/20 0.44
CHRM1 P11229 2/20 0.44
CHRM3 P20309 2/20 0.44
PGR P06401 1/20 0.44
CHRM2 P08172 1/20 0.44
CHRM4 P08173 1/20 0.44
HTR1A P08908 1/20 0.44
CHRNB2 P17787 1/20 0.44
TBXA2R P21731 1/20 0.44
CHRNB4 P30926 1/20 0.44
CHRNA3 P32297 1/20 0.44
CHRNA7 P36544 1/20 0.44
CHRNA4 P43681 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2166231 1.00 ALDH1A1 (0.58) ALDH1A1ACHELMNAAPOBEC3AAPOBEC3G
SCHEMBL28557072 1.00 ALDH1A1 (0.58) ALDH1A1ACHELMNAAPOBEC3AAPOBEC3G
SCHEMBL1263280 1.00 ALDH1A1 (0.58) ALDH1A1ACHELMNAAPOBEC3AAPOBEC3G
SCHEMBL11782337 1.00 ALDH1A1 (0.58) ALDH1A1ACHELMNAAPOBEC3AAPOBEC3G
SCHEMBL6060605 1.00 ALDH1A1 (0.58) ALDH1A1ACHELMNAAPOBEC3AAPOBEC3G
SCHEMBL6060753 1.00 ALDH1A1 (0.58) ALDH1A1ACHELMNAAPOBEC3AAPOBEC3G
SCHEMBL20067030 1.00 ALDH1A1 (0.58) ALDH1A1ACHELMNAAPOBEC3AAPOBEC3G
SCHEMBL6060438 1.00 ALDH1A1 (0.58) ALDH1A1ACHELMNAAPOBEC3AAPOBEC3G
SCHEMBL763021 1.00 ALDH1A1 (0.58) ALDH1A1ACHELMNAAPOBEC3AAPOBEC3G
SCHEMBL11781090 1.00 ALDH1A1 (0.58) ALDH1A1ACHELMNAAPOBEC3AAPOBEC3G

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180108944-A1 GRAPHENE COMPOUND AND MANUFACTURING METHOD THEREOF, ELECTROLYTE, AND POWER STORAGE DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2018-04-19 US disclosed
EP-1706368-A1 PROCESS FOR PREPARING MONOESTERS 3M Innovative Properties Company (US) 2006-10-04 EP disclosed
WO-2005066108-A1 PROCESS FOR PREPARING MONOESTERS 3M INNOVATIVE PROPERTIES COMPANY (US) 2005-07-21 WO disclosed
US-20050143599-A1 Process for preparing monoesters 3M INNOVATIVE PROPERTIES COMPANY 2005-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050143599-A1 Process for preparing monoesters ADSL, COASY, AGPS ALDH1A1 217/4885ACHE 2406/4885LMNA 1552/4885
US-20180108944-A1 GRAPHENE COMPOUND AND MANUFACTURING METHOD THEREOF, ELECTROLYTE, AND POWER STORAGE DEVICE ILK, GK, KCNH3 ALDH1A1 1003/4885ACHE 2948/4885LMNA 554/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.